2022 annual financial data

Sagimet Biosciences 2022 Financial results

Direct answer

Revenue was 0 USD.

Operating income was -31,055,000 USD and net income was -30,499,000 USD.
Operating cash flow was -24,490,000 USD.

Get free Sagimet Biosciences email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-31,055,000 USD
Net income
-30,499,000 USD
Operating cash flow
-24,490,000 USD